Merck

The alliance will leverage Atropos Health's platform, GENEVA OS, and evidence network for advanced data and analysis.  

Also, Standigm has partnered with Merck Korea for AI drug discovery research.

The lab, which works with AstraZeneca, Merck, Pfizer, Israel Biotech Fund, Teva Pharmaceuticals, and Amazon Web Services, is currently accepting applicants for its new challenge. 

The alliance is starting out by supporting research into how social media can be leveraged to increase confidence in and uptake of COVID-19 vaccines.   

This week's top stories include a plea to increase efforts to collect ethnicity data when administering vaccinations, and Apple and the University of Michigan sharing the first results from the Apple Hearing Study.

Remote patient monitoring, cloud-based platform services and AI-enabled ultrasound diagnoses will be used to improve outcomes in fertility treatment.  

The partnership will leverage on Holmusk’s GlycoLeap platform to help patients achieve weight loss and improved blood glucose control. 

Also: Hims and Hers expands to all 50 states; VC firm Freestyle Capital offers Meru to portfolio companies. 

Both companies will also jointly explore how to break down the barrier between online and offline healthcare by means of innovative retail models connecting retail pharmacies, hospitals and primary healthcare in rural areas.

The Boston-based company has now raised a hair over $90 million for its AI pathology platform.